Mouse study links CBD’s anxiety-like effects to LHb α3 glycine receptors
Cannabidiol alleviates anxiety-like behaviors via α3-containing glycine receptors in the lateral habenula.
AI Summary
This study asked whether cannabidiol (CBD) reduces anxiety-like behavior through glycine receptors in the lateral habenula (LHb). Using behavioral tests and brain-cell recordings in mice, the researchers found that giving CBD either systemically or directly into the LHb alleviated anxiety-like behaviors. Blocking LHb glycine receptors caused anxiety-like behaviors, and CBD did not reverse those behaviors after the receptors had been blocked.
Further experiments identified α3-containing glycine receptors as necessary for the observed effects: deleting this receptor subtype in the LHb produced anxiety-like behaviors and eliminated CBD’s behavioral and neuronal effects, while deleting the α1 subtype did not produce the same result. CBD also reduced LHb neuron excitability when α3-containing receptors were present. These mouse findings identify a possible mechanism, but the abstract does not establish that CBD treats anxiety disorders in people; it reports no human results, and this abstract-based summary cannot assess the study’s full methods or limitations.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
Randomized trial finds CBD did not reduce severe behavioral problems
Preclinical evidence finds no stable CBD dose-response for fear
Post hoc TSC analysis links caregiver-perceived improvement to seizure…
Explore More Research
Stay informed about the latest cannabis science.